WO1997007273A1 - Nonwoven fabric or silk for medical supplies - Google Patents
Nonwoven fabric or silk for medical supplies Download PDFInfo
- Publication number
- WO1997007273A1 WO1997007273A1 PCT/JP1996/002271 JP9602271W WO9707273A1 WO 1997007273 A1 WO1997007273 A1 WO 1997007273A1 JP 9602271 W JP9602271 W JP 9602271W WO 9707273 A1 WO9707273 A1 WO 9707273A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- silk
- fibers
- nonwoven fabric
- medical
- gauze
- Prior art date
Links
- 239000004745 nonwoven fabric Substances 0.000 title claims abstract description 28
- 239000000835 fiber Substances 0.000 claims abstract description 57
- 238000000034 method Methods 0.000 claims description 18
- 238000005520 cutting process Methods 0.000 claims description 7
- 239000004744 fabric Substances 0.000 claims description 3
- 101100393514 Rattus norvegicus Gzmm gene Proteins 0.000 claims 4
- 239000007788 liquid Substances 0.000 abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 238000004080 punching Methods 0.000 abstract description 3
- 239000011230 binding agent Substances 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 description 15
- 241000283973 Oryctolagus cuniculus Species 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- 229920000742 Cotton Polymers 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 239000002689 soil Substances 0.000 description 7
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 210000001165 lymph node Anatomy 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 208000030961 allergic reaction Diseases 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 238000009991 scouring Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009960 carding Methods 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 230000005951 type IV hypersensitivity Effects 0.000 description 2
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 108010013296 Sericins Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000003665 fog water Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/40—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
- D04H1/44—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties the fleeces or layers being consolidated by mechanical means, e.g. by rolling
- D04H1/46—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties the fleeces or layers being consolidated by mechanical means, e.g. by rolling by needling or like operations to cause entanglement of fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/40—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
- D04H1/44—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties the fleeces or layers being consolidated by mechanical means, e.g. by rolling
- D04H1/46—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties the fleeces or layers being consolidated by mechanical means, e.g. by rolling by needling or like operations to cause entanglement of fibres
- D04H1/492—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties the fleeces or layers being consolidated by mechanical means, e.g. by rolling by needling or like operations to cause entanglement of fibres by fluid jet
Definitions
- the present invention relates to a medical nonwoven fabric used for gauze, bandages, sheets, surgical gowns and the like. Background art
- Some of the so-called surgical gauze include an affected gauze used to protect the tissue during surgery, a square gauze (wiper) used for absorption and wiping, and our gauze used for surgical procedures (Dressing).
- Surgical gauze has the following roles:
- the affected area gauze is currently made of rayon cotton and spunlace blended with polyester for strength. Have been done.
- cotton yarn woven gauze is used for dressing to absorb or protect wound exudate.
- this gauze is basically 30 cm in width and is cut or folded according to the size of the wound.
- it is difficult to use the lint after cutting or to fold it.
- nonwoven fabrics are widely used in the medical field, such as sheets and surgical gowns, but most of the nonwoven fabrics conventionally used are made of synthetic fibers such as nylon and polyester.
- the present invention has been made to solve such problems, and one of the objects thereof is to have sufficient absorbency, sufficient softness not to damage body tissues, and An object of the present invention is to provide a surgical gauze with less rejection from body tissues. It also provides materials that can be widely used for other medical uses. Disclosure of the invention
- the medical nonwoven fabric according to the present invention which has been made to solve the above-mentioned problem, is characterized in that the medical nonwoven fabric is made of only short fibers obtained by cutting silk fibers. Therefore, no binder (adhesive) is used to fix the fibers.
- the silk fibers may be unrefined or refined. Unrefined products can be produced at low cost, so they are suitable for use in sheets, blankets, medical clothing, and the like. It is also suitable for applications that require a high degree of chemical rejection, because there is no risk of residual chemicals during scouring. On the other hand, by performing scouring, part or all of the sericin layer on the surface is removed, and at the same time, dirt on the surface is also removed. When required, it is desirable to use refined silk fibers. Such scoured silk fibers are used for surgical gauze such as the affected area gauze, wiper, and dressing described above. However, in this case, perform sufficient de-chemical treatment after scouring.
- the length of the short fiber is about l to 10 cm. If the length is shorter than this, the entanglement becomes insufficient and the print tends to occur. In addition, even if the length is longer than this, the entanglement does not work well, and the nonwoven fabric has a lot of fraying. In addition, it is more preferably about 5 to 7 cm.
- the entanglement for forming the silk short fibers into a nonwoven fabric any of a needle punching method and a hydroentanglement method used in general nonwoven fabric production can be employed.
- the nonwoven fabric according to the present invention is produced as follows. First, unrefined or refined raw silk fibers (filament fibers) are cut into appropriate lengths to make short fibers. This is removed by carding to remove short fibers of less than a predetermined length and impurities to form a sliper. Before the carding, different types of silk fibers may be mixed (mixed). Slivers generated continuously are cut at appropriate intervals by Athenyue. At this time, cut the sliver so as not to cut the short silk fiber.
- a slicer cut to an appropriate length is placed on a net, and the net is vibrated to form a fleece (fiber accumulation layer). Keep the fleece slightly moist.
- a method of giving moisture to the fleece a method such as spraying fog water on the fleece or increasing the humidity of the atmosphere can be used. This removes static electricity due to friction between the silk fibers, prevents separation between the silk fibers due to static electricity, and facilitates formation of a fleece. Further, in the needle punching step described later, the degree of adhesion between the needle and the fiber is increased, and the entanglement of the fiber is facilitated.
- the rotatable blade supported by the hanging bar is inserted into the moving fleece.
- the blades rotate as the fleece moves, stirring the silk fibers in the fleece and removing short waste fibers (dust).
- the fiber is entangled by repeatedly passing the needle through the fleece, Obtain an integrated nonwoven. Finally, the thickness is made uniform by pressing with a heating roller.
- a high-pressure columnar water stream is similarly sprayed onto the filtered fleece to entangle the fibers.
- any one produced by the needle punch method or the hydroentanglement method can be used.
- the liquid retention ability the ability to absorb and hold blood and other liquids
- the one manufactured by the 21 dollar punch method is more suitable, and the one manufactured by the hydroentanglement method is more suitable when emphasis is placed on strength or low lintability.
- the nonwoven fabric of the present invention is made of silk, its properties do not change as long as it is subjected to heat sterilization treatment or gas sterilization treatment (EOG) similar to conventional cotton yarn gauze.
- EOG gas sterilization treatment
- a urethane thread or the like for X-ray detection may be embedded.
- the medical non-woven fabric according to the present invention includes, in addition to the surgical gauze described above, a bandage, a base cloth for a patch, a gauze for an emergency bandage (also referred to as a wound tape, for example, a brand name band aid), a surgical gown, a mask, Can be used for sheets, filters, etc.
- a bandage also referred to as a wound tape, for example, a brand name band aid
- a surgical gown for example, a brand name band aid
- a mask can be used for sheets, filters, etc.
- the invention's effect is desirable to appropriately change the basis weight and the like according to each of these uses.
- the nonwoven fabric according to the present invention is composed only of silk fibers. Therefore, it can be used with confidence even on parts that directly touch the skin or body tissues.
- the results of examining the allergic properties of silk fiber by comparison with rabbit hair are described below.
- the experimental method used is as follows. First, 5 mg each of silk fiber and rabbit hair are subcutaneously planted in an ICR mouse (a type of hybrid mouse).
- mice were inoculated with a solution (0.1% aqueous solution) of the same silk fiber or rabbit hair dissolved in water having a weight of 100 times the weight (0.1% aqueous solution), and the thickness of the footpad was measured.
- the strength of the allergic reaction was examined by the weight of the popliteal lymph node and the weight of the popliteal lymph node.
- Footpad thickness (10 m) Antigen Antigen inoculated side Inoculated saline side Increased amount Silk (0.1% aqueous solution) 1 300 300 0
- the medical nonwoven fabric according to the present invention is made of silk, so that it is soft and hardly makes any fine scratches on the surface even when the body tissue is wiped.
- the silk fiber itself has a large liquid absorption capacity, and a relatively densely packed nonwoven fabric can improve the liquid absorption capacity depending on the tissue.
- a gauze having a liquid absorption capacity about 2 to 5 times that of cotton gauze can be obtained. Therefore, when used as a wiper during surgery, a relatively small amount of gauze can be sufficiently absorbed by simply applying it without wiping as in the past, so that the affected part can be seen better, and rapid And it will greatly help the progress of certain operations.
- the surface of internal organs or the like is wiped with the gauze according to the present invention in order to see the affected part better, the surface of the tissue is rarely damaged. Furthermore, since it is composed of only silk fibers, which are animal fibers without impurities, it does not stimulate the internal organs, wounds, etc. even if they come into contact with them. There are few problems. In addition, since it is made of silk fiber, which is a natural material, there is no problem of disposal after use, unlike nonwoven fabric using synthetic fibers.
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mechanical Engineering (AREA)
- Textile Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Nonwoven Fabrics (AREA)
Abstract
Silk fibers are cut into short fibers having a length of about 1 to 10 cm, from which a nonwoven fabric is prepared by needle punching or water stream entanglement without using any binder. This nonwoven fabric has a satisfactory liquid absorbency and is so soft that it does not damage the internal tissues. It is therefore suitable for medical supplies such as surgical gauzes. Scoured silk fibers are used for surgical gauzes, while both scoured and unscoured silk fibers are used for sheet and so forth.
Description
明 細 書 医療用絹不織布 技術分野 Technical Description Medical silk nonwovens Technical field
本発明は、 ガーゼ、 包帯、 シーツ、 手術着等に用いられる医療用不織布に関す る。 背景技術 The present invention relates to a medical nonwoven fabric used for gauze, bandages, sheets, surgical gowns and the like. Background art
手術用ガーゼと称されるものの中には、 手術中に組織保護用と して使われる患 部ガーゼ、 吸収や拭き取り用として使われる尺角ガーゼ (ワイパー) 、 及び、 外 科処置に使う当ガーゼ (ドレッシング) 等がある。 Some of the so-called surgical gauze include an affected gauze used to protect the tissue during surgery, a square gauze (wiper) used for absorption and wiping, and our gauze used for surgical procedures (Dressing).
手術用ガーゼには、 次のような役割がある。 Surgical gauze has the following roles:
① 血液 ·排水の吸収 ① Absorption of blood and wastewater
② 手術部位の仕切り ② Partition of the surgical site
③ 組織 · 器官 ·切開組織の保護とクッショ ン ③ Tissue, organs, incised tissue protection and cushioning
これらの役割を果たすため、 手術用ガーゼには次のような特性が要求される。 a . X線造影性が高く、 カウントが容易 To fulfill these roles, surgical gauze is required to have the following characteristics. a. High X-ray contrast and easy counting
b . 折り畳んだり、 開いたりすることが容易 b. Easy to fold and open
c 機能的に十分な乾 · 湿強度 c Functionally sufficient dry and wet strength
d . 低リ ント性 · ほつれに対する抵抗性 d. Low lint and resistance to fraying
e . 速い液体吸い上げ性と · 高い吸収量 e. Fast liquid absorption and high absorption
f . 組織接触時に組織表面に外傷を与えない f. Do not cause trauma to the tissue surface when contacting the tissue
, g . 組織の水和作用のために最適の液体保持性能 , g. Optimal fluid retention for tissue hydration
h . 水蒸気 · ガス '放射線によって滅菌可能 h. Steam and gas can be sterilized by radiation
i . 高速加工 · 低コス ト i. High-speed machining, low cost
j . 安全性と毒物の規格への適合 j. Compliance with safety and toxicological standards
このような要求に応えられるものとして、 現在、 患部ガーゼと しては、 レ一ョ ン · コッ トンと強度を出すためのポリエステルをプレンドしたスパンレースが使
われている。 また、 創部の浸出液の吸収或いは保護を目的とする ドレッシングに は、 綿糸織布ガーゼが使用されている。 一般に、 このガーゼは幅 3 0 c mの原反 (尺角) が基本で、 それを創部の大きさに応じてカッ ト し或いは折り畳んで使わ れているが、 裁断した後の糸くずや折り畳む手間などの欠点が存在する (日本医 科器械学会監修 「医療用不織布ハンドブック」 , 1 9 9 4年 1 0月, 株式会社南 山堂発行) 。 In order to meet such demands, the affected area gauze is currently made of rayon cotton and spunlace blended with polyester for strength. Have been done. In addition, cotton yarn woven gauze is used for dressing to absorb or protect wound exudate. Generally, this gauze is basically 30 cm in width and is cut or folded according to the size of the wound. However, it is difficult to use the lint after cutting or to fold it. (Medical non-woven fabric handbook, supervised by the Japan Society of Medical Instruments, October 1998, published by Nanzando Co., Ltd.)
一方、 不織布はシーツ、 手術着等、 医療の各分野において広く用いられている が、 従来用いられている不織布は、 いずれもナイロン、 ポリエステル等の合成繊 維を用いたものが殆どであった。 On the other hand, nonwoven fabrics are widely used in the medical field, such as sheets and surgical gowns, but most of the nonwoven fabrics conventionally used are made of synthetic fibers such as nylon and polyester.
従来の綿糸織布ガーゼは古くから使用されているため、 その安全性は立証され ているが、 上記糸くずの欠点を有する他、 液体吸収力が必ずしも十分ではないた め、 創部の出血が多い場合には何度も交換する必要があった。 また、 綿糸ガーゼ は一見柔らかいように見えるが、 体内組織に対しては比較的硬く、 体内組織の表 面に細かい疵を付けるという欠点がある。 また、 綿繊維は必ずしも体内組織との 適合性が十分ではなく、 繊維の一部が体内に残留した場合には拒絶反応が生じる ことが避けられなかった。 Conventional cotton yarn woven gauze has been used for a long time, and its safety has been proven.However, in addition to the drawbacks of the above-mentioned lint, the wound absorbs a large amount due to insufficient liquid absorbency. In that case it had to be replaced many times. In addition, cotton yarn gauze appears to be soft at first glance, but has a disadvantage that it is relatively hard on body tissue and makes fine scratches on the surface of body tissue. In addition, cotton fibers were not always sufficiently compatible with tissues in the body, and if some of the fibers remained in the body, it was inevitable that rejection would occur.
本発明はこのような課題を解決するために成されたものであり、 その目的とす るところの一つは、 十分な吸収性を持ち、 体内組織を傷つけない十分な柔らかさ を持ち、 しかも体内組織からの拒絶反応の少ない手術用ガーゼを提供することに ある。 また、 それ以外の医療用途にも広く用いることができる素材を提供する。 発明の開示 The present invention has been made to solve such problems, and one of the objects thereof is to have sufficient absorbency, sufficient softness not to damage body tissues, and An object of the present invention is to provide a surgical gauze with less rejection from body tissues. It also provides materials that can be widely used for other medical uses. Disclosure of the invention
上記課題を解決するために成された本発明に係る医療用不織布は、 絹繊維を切 断した短繊維のみから成ることを特徴とするものである。 従って、 繊維を固定す るためのパインダ (接着剤) も使用しない。 The medical nonwoven fabric according to the present invention, which has been made to solve the above-mentioned problem, is characterized in that the medical nonwoven fabric is made of only short fibers obtained by cutting silk fibers. Therefore, no binder (adhesive) is used to fix the fibers.
絹繊維は、 未精練のもの、 精練を行なったもののどちらでもよい。 未精練のも のは当然低コス トで製造できるため、 シーツや毛布、 医療用衣服等に用いる場合 に適している。 また、 精練時の薬品の残留の心配がないため、 高度の薬品排除性 を要求される用途にも適している。
一方、 精練を行なうことにより表面のセリシン層の一部又は全部が除去され、 同時に表面の汚れも除去されるため、 高度の柔軟性、 (生体組織に傷を付けない) 柔らかさ及び清浄性を要求される場合には精練済みの絹繊維を用いることが望ま しい。 上記の患部ガーゼ、 ワイパー、 ドレッシング等の手術用ガーゼには、 この ような精練を行なった絹繊維を用いる。 但し、 この場合には精練後充分な脱薬品 処理を行なう。 The silk fibers may be unrefined or refined. Unrefined products can be produced at low cost, so they are suitable for use in sheets, blankets, medical clothing, and the like. It is also suitable for applications that require a high degree of chemical rejection, because there is no risk of residual chemicals during scouring. On the other hand, by performing scouring, part or all of the sericin layer on the surface is removed, and at the same time, dirt on the surface is also removed. When required, it is desirable to use refined silk fibers. Such scoured silk fibers are used for surgical gauze such as the affected area gauze, wiper, and dressing described above. However, in this case, perform sufficient de-chemical treatment after scouring.
短繊維の長さは l ~ 1 0 c m程度とする。 これより短いと絡合が不十分となる とともに、 リ ン トが発生しやすく なる。 また、 これより長く ても絡合がうまく ゆ かず、 ほつれの多い不織布となる。 なお、 更に好ましく は 5〜7 c m程度とする。 絹短繊維を不織布とするための絡合には、 一般の不織布製造に用いられる二一 ドルパンチ法、 水流絡合法のいずれをも採用することができる。 The length of the short fiber is about l to 10 cm. If the length is shorter than this, the entanglement becomes insufficient and the print tends to occur. In addition, even if the length is longer than this, the entanglement does not work well, and the nonwoven fabric has a lot of fraying. In addition, it is more preferably about 5 to 7 cm. As the entanglement for forming the silk short fibers into a nonwoven fabric, any of a needle punching method and a hydroentanglement method used in general nonwoven fabric production can be employed.
ニードルパンチ法の場合、 本発明に係る不織布は次のようにして作製する。 ま ず、 未精練又は精練後の原絹繊維 (長繊維) を適宜の長さに切断して、 短繊維と する。 これをカーディ ングにより所定長さ以下の短繊維及び不純物を除き、 スラ ィパとする。 なお、 カーデイ ングの前に、 異なった種類の絹繊維を混合 (ミキシ ング) してもよい。 連続して生成されるスライパは、 ァテニユエ一夕により適宜 の彔さ毎に切断する。 このとき絹短繊維を切断しないように、 スライバを引きち ぎるように切断する。 In the case of the needle punch method, the nonwoven fabric according to the present invention is produced as follows. First, unrefined or refined raw silk fibers (filament fibers) are cut into appropriate lengths to make short fibers. This is removed by carding to remove short fibers of less than a predetermined length and impurities to form a sliper. Before the carding, different types of silk fibers may be mixed (mixed). Slivers generated continuously are cut at appropriate intervals by Athenyue. At this time, cut the sliver so as not to cut the short silk fiber.
適宜の長さに切断されたスライパを網の上に載せ、 網を振動させることにより、 フリース (繊維の集積層) を形成する。 その際、 フリースに僅かの湿気を与えて おく。 フリースに湿気を与える方法としては、 フリースに霧状の水を噴霧したり、 雰囲気の湿度を高く しておく等の方法をとることができる。 これにより、 絹繊維 間の摩擦による静電気を除去し、 絹繊維相互の静電気による離反を防止して、 フ リースの形成を容易にする。 また、 後述のニードルパンチ工程において、 針と繊 維との粘着度を増し、 繊維の絡合を容易にする。 A slicer cut to an appropriate length is placed on a net, and the net is vibrated to form a fleece (fiber accumulation layer). Keep the fleece slightly moist. As a method of giving moisture to the fleece, a method such as spraying fog water on the fleece or increasing the humidity of the atmosphere can be used. This removes static electricity due to friction between the silk fibers, prevents separation between the silk fibers due to static electricity, and facilitates formation of a fleece. Further, in the needle punching step described later, the degree of adhesion between the needle and the fiber is increased, and the entanglement of the fiber is facilitated.
次に、 移動するフリースの中に、 垂下棒により支えられた回転可能な羽根を挿 入する。 羽根はフリースの移動に伴い回転し、 フリース内の絹繊維の攪拌を行な うとともに、 短いクズ繊維を除去する (濾塵) 。 Next, the rotatable blade supported by the hanging bar is inserted into the moving fleece. The blades rotate as the fleece moves, stirring the silk fibers in the fleece and removing short waste fibers (dust).
そして、 フリースにニードルを繰り返し貫通させることにより繊維を絡ませ、
一体化された不織布を得る。 最後に加熱ローラで加圧することにより厚さを揃え、 兀成 とす O And the fiber is entangled by repeatedly passing the needle through the fleece, Obtain an integrated nonwoven. Finally, the thickness is made uniform by pressing with a heating roller.
また、 水流絡合法の場合は、 同様に濾塵を行なったフリースに高圧の柱状の水 流を噴射して、 繊維の絡合を行なう。 In the case of the water entanglement method, a high-pressure columnar water stream is similarly sprayed onto the filtered fleece to entangle the fibers.
手術用ガーゼとしては、 ニードルパンチ法、 水流絡合法のいずれの方法で作製 したものでも用いることができるが、 保液能 (血液等の液体を吸収し、 保持して おく能力) を重視する場合には二一ドルパンチ法で作製したものの方が適してお り、 強度或いは低リ ント性を重視する場合には水流絡合法で作製したものの方が 適している。 As the surgical gauze, any one produced by the needle punch method or the hydroentanglement method can be used. However, when emphasis is placed on the liquid retention ability (the ability to absorb and hold blood and other liquids) The one manufactured by the 21 dollar punch method is more suitable, and the one manufactured by the hydroentanglement method is more suitable when emphasis is placed on strength or low lintability.
ガーゼ用としては、 二一ドルパンチ法で作製した場合は 5 0〜 2 0 0 g / m m 2程度、 水流絡合法で作製した場合は 2 0 - 1 0 0 g Z m m 2程度 (望ましく は 2 0〜6 0 g / m m 2程度) の目付が適当である。 また、 原料とする絹繊維の長さも, 水流絡合法の場合はニードルパンチ法の場合よりもやや長めにしておく。 発明を実施するための最良の形態 For gauze, about 50 to 200 g / mm 2 when manufactured by the 21 dollar punch method, and about 20 to 100 g Z mm 2 when manufactured by the hydroentanglement method (preferably 20 mm (Approximately 60 g / mm 2 ) is appropriate. Also, the length of the silk fiber used as the raw material should be slightly longer in the case of the hydroentanglement method than in the case of the needle punch method. BEST MODE FOR CARRYING OUT THE INVENTION
手術用ガーゼとして使用する際は、 従来のガーゼと同様、 シンメルゃケッテル 等で加熟することにより殺菌を行なう。 本発明の不織布は絹を素材とするが、 従 来の綿糸ガーゼと同様の加熱殺菌処理やガス滅菌処理 (E O G ) 等を行なう限り、 その特性が変化することはない。 また、 従来の手術用ガーゼと同様、 X線検出用 のウレタン糸等を埋設しておいてもよい。 When used as surgical gauze, it is sterilized by ripening with Simmel Kettel or the like, as with conventional gauze. Although the nonwoven fabric of the present invention is made of silk, its properties do not change as long as it is subjected to heat sterilization treatment or gas sterilization treatment (EOG) similar to conventional cotton yarn gauze. Further, as with the conventional surgical gauze, a urethane thread or the like for X-ray detection may be embedded.
本発明に係る医療用不織布は、 上記説明した手術用ガーゼの他、 包帯、 貼付薬 用の基布、 救急絆創膏 (傷テープとも言う。 例えば商品名バンドエイ ド) 用ガー ゼ、 手術着、 マスク、 シーツ、 フィルタ等に使用することができる。 もちろん、 これらの各用途に応じて目付等を適宜変更することが望ましい。 発明の効果 The medical non-woven fabric according to the present invention includes, in addition to the surgical gauze described above, a bandage, a base cloth for a patch, a gauze for an emergency bandage (also referred to as a wound tape, for example, a brand name band aid), a surgical gown, a mask, Can be used for sheets, filters, etc. Of course, it is desirable to appropriately change the basis weight and the like according to each of these uses. The invention's effect
手術用の縫合糸には従来より絹糸が用いられており、 その人体適合性について 問題がないことは既に実証されている。 そして、 絹繊維はアレルギーを起こすこ とが少ないことも知られている。 本発明に係る不織布は絹繊維のみで構成されて
いるため、 肌や体内組織に直接触れる部分にも安心して使用することができる。 絹繊維のアレルギー特性を、 兎毛との比較により調べた結果を以下に説明する 用いた実験方法は次の通りである。 まず、 絹繊維および兎毛それぞれ 5 mgを I C Rマウス (雑種マウスの一種) の皮下に植える。 3週間後、 同じ絹繊維あるいは 兎毛をその 1 0 0 0倍の重量の水に溶かした液 (0 . 1 %水溶液) をマウスの足 の裏 (footpad) に接種し、 f ootpadの厚さおよび膝窩リ ンパ節の重さによりァレ ルギー反応の強さを調べた。
Conventionally, silk sutures have been used for surgical sutures, and it has already been demonstrated that there is no problem with human compatibility. It is also known that silk fibers are less likely to cause allergies. The nonwoven fabric according to the present invention is composed only of silk fibers. Therefore, it can be used with confidence even on parts that directly touch the skin or body tissues. The results of examining the allergic properties of silk fiber by comparison with rabbit hair are described below. The experimental method used is as follows. First, 5 mg each of silk fiber and rabbit hair are subcutaneously planted in an ICR mouse (a type of hybrid mouse). Three weeks later, mice were inoculated with a solution (0.1% aqueous solution) of the same silk fiber or rabbit hair dissolved in water having a weight of 100 times the weight (0.1% aqueous solution), and the thickness of the footpad was measured. The strength of the allergic reaction was examined by the weight of the popliteal lymph node and the weight of the popliteal lymph node.
表 1 Delayed - Type Hypersensitivity (実験 1 ) Table 1 Delayed-Type Hypersensitivity (Experiment 1)
Footpad の厚さ (10 m) 抗原 抗原接種側 . 生食接種側 増加分 絹(0· 1%水溶液) 1 325 340 -15 Footpad thickness (10 m) Antigen Antigen-inoculated side. Inoculated saline side Increased amount Silk (0.1% aqueous solution) 1 325 340 -15
2 335 335 0 2 335 335 0
3 335 330 53 335 330 5
4 325 315 104 325 315 10
Mean土 SD 330±6 330±11 0±11 兎毛(0.1%水溶液) 1 380 325 55 Mean soil SD 330 ± 6 330 ± 11 0 ± 11 Rabbit hair (0.1% aqueous solution) 1 380 325 55
2 385 335 50 2 385 335 50
3 380 340 403 380 340 40
4 375 320 554 375 320 55
Mean土 SD 380±4 330± 9 50±7 膝窩リンパ節の重さ (nig) 抗原 抗原接種側 生食接種側 増加分 絹(0.1%水溶液) 1 2.5 3.2 —0.7 Mean soil SD 380 ± 4 330 ± 9 50 ± 7 Weight of popliteal lymph node (nig) Antigen Inoculated antigen side Inoculated saline side Increased amount Silk (0.1% aqueous solution) 1 2.5 3.2 —0.7
2 3.3 3.3 0 2 3.3 3.3 0
3 3.3 3.4 -0.1 3 3.3 3.4 -0.1
A 9 A 9 <i n 1A 9 A 9 <i n 1
Mean土 SD 2.88± 0.49 3.05±0.51 - 0.18±0.36 兎毛(0.1%水溶液) 1 5.8 2.1 3.7 Mean soil SD 2.88 ± 0.49 3.05 ± 0.51-0.18 ± 0.36 Rabbit hair (0.1% aqueous solution) 1 5.8 2.1 3.7
2 6.1 2.9 3.2 2 6.1 2.9 3.2
3 3.7 3.5 0.2 3 3.7 3.5 0.2
4 5.1 3.6 1.5 4 5.1 3.6 1.5
Mean土 SD 5.18± 1.07 3.03± 0.69 2.15±1.61 絹繊維あるいは兎毛それぞれ(5mg)を I C Rマウスの皮下に植え、 3週間後絹繊維 あるいは兎毛の原料重量に対して 1000倍液(0.1%水溶液)を footpadに接種し、 ァ レルギ一反応を調べた。
表 2 Delayed - Type Hypersensitivity (実験 2 ) Mean soil SD 5.18 ± 1.07 3.03 ± 0.69 2.15 ± 1.61 Silk fiber or rabbit hair (5 mg) was subcutaneously implanted in ICR mice, and after 3 weeks, 1000 times the weight of the raw material of silk fiber or rabbit hair (0.1% aqueous solution) ) Was inoculated into a footpad, and the allergic reaction was examined. Table 2 Delayed-Type Hypersensitivity (Experiment 2)
Footpad の厚さ (10〃m) 抗原 抗原接種側 生食接種側 増加分 絹(0.1%水溶液) 1 300 300 0 Footpad thickness (10 m) Antigen Antigen inoculated side Inoculated saline side Increased amount Silk (0.1% aqueous solution) 1 300 300 0
2 295 290 5 2 295 290 5
3 300 300 0 3 300 300 0
4 ' 310 305 5 4 '310 305 5
Mean土 SD 301±6 299±6 3±3 兎毛(0.1%水溶液) 1 340 300 40 Mean soil SD 301 ± 6 299 ± 6 3 ± 3 Rabbit hair (0.1% aqueous solution) 1 340 300 40
2 345 300 45 2 345 300 45
3 350 295 55 3 350 295 55
4 35-5 310 45 4 35-5 310 45
Mean土 SD 348± 6 301± 6 46±6 膝窩リ ンパ節の重さ (mg) 抗原 抗原接種側 生食接種側 増加分 絹(0.1%水溶液) 1 2.1 1.9 0.2 Mean soil SD 348 ± 6 301 ± 6 46 ± 6 Weight of popliteal lymph node (mg) Antigen Antigen inoculated side Inoculated saline side Increased amount Silk (0.1% aqueous solution) 1 2.1 1.9 0.2
2 1.8 1.9 -0.1 2 1.8 1.9 -0.1
3 1.8 1.7 0.1 3 1.8 1.7 0.1
4 1.8 1.8 0 4 1.8 1.8 0
Mean士 SD 1.88±0.15 1.83± 0.10 0.05±0.13 兎毛(0.1%水溶液) 1 3.1 1.6 1.5 Meaner SD 1.88 ± 0.15 1.83 ± 0.10 0.05 ± 0.13 Rabbit hair (0.1% aqueous solution) 1 3.1 1.6 1.5
2 4.6 2.4 2.2 2 4.6 2.4 2.2
3 4.2 1.8 2.4 3 4.2 1.8 2.4
4 2.7 1.9 0.8 4 2.7 1.9 0.8
Mean土 SD 3.65± 0.90 1.93± 0.34 1.73±0.73 絹繊維あるいは兎毛それぞれ(5mg)を I C Rマウスの皮下に植え、 3週間後絹繊維 あるいは兎毛の原料重量に対して 1000倍液(0.1%水溶液)を footpadに接種し、 ァ レルギ一反応を調べた。
表 1及び表 2は 2回の実験の結果をそれぞれまとめたもので、 footpadの厚さ及 び膝窩リ ンパ節の重さのいずれの指標においても、 絹 0 . 1 %溶液の場合には増 加量がほぼゼロに近いのに対し、 兎毛 0 . 1 %溶液の場合には有意な増加が現わ れている。 すなわち、 絹繊維がアレルギーを殆ど こすことがないことが実験的 に証明されている。 Mean soil SD 3.65 ± 0.90 1.93 ± 0.34 1.73 ± 0.73 Silk fiber or rabbit hair (5 mg) was inoculated subcutaneously into ICR mice, and after 3 weeks, 1000 times the weight of the silk fiber or rabbit hair material (0.1% aqueous solution) ) Was inoculated into a footpad, and the allergic reaction was examined. Tables 1 and 2 summarize the results of the two experiments, respectively, for both the thickness of the footpad and the weight of the popliteal lymph node, for the 0.1% silk solution. The increase was nearly zero, whereas a 0.1% rabbit hair solution showed a significant increase. That is, it has been experimentally proved that silk fibers hardly cause allergy.
次に、 本発明に係る医療用不織布は、 絹を素材とするため柔らかく、 体内組織 を拭っても表面に細かい疵を付けることがほとんどない。 また、 素材である絹繊 維自体が大きな液体吸収能を有する上、 比較的密に集積した不織布組織とするこ とにより、 組織によっても液体吸収能を向上することができ、 これらによって、 従来の綿糸ガーゼの 2〜 5倍程度の液体吸収能を有するガーゼとすることができ る。 そのため、 手術中にワイパーとして用いる場合、 比較的少ない量のガーゼで、 しかも従来のように拭うことなく当てるだけでも血液を充分に吸収することがで きるため、 患部が良く見えるようになり、 迅速且つ確実な手術の進行の大いなる 助けとなる。 また、 患部を更に良く見るために本発明に係るガーゼで内臓等の表 面を拭っても、 組織表面に傷を付けることが少ない。 更に、 不純物を含まず、 動 物繊維である絹繊維のみで構成されているため、 内臓、 創部等に接触してもそれ らを刺激することが少なく、 また、 たとえ一部が体内に残留しても問題が少ない。 また、 自然物である絹繊維を素材とするため、 合成繊維を用いた不織布のよう な使用後の廃棄処理の問題がない。
Next, the medical nonwoven fabric according to the present invention is made of silk, so that it is soft and hardly makes any fine scratches on the surface even when the body tissue is wiped. In addition, the silk fiber itself has a large liquid absorption capacity, and a relatively densely packed nonwoven fabric can improve the liquid absorption capacity depending on the tissue. A gauze having a liquid absorption capacity about 2 to 5 times that of cotton gauze can be obtained. Therefore, when used as a wiper during surgery, a relatively small amount of gauze can be sufficiently absorbed by simply applying it without wiping as in the past, so that the affected part can be seen better, and rapid And it will greatly help the progress of certain operations. Further, even if the surface of internal organs or the like is wiped with the gauze according to the present invention in order to see the affected part better, the surface of the tissue is rarely damaged. Furthermore, since it is composed of only silk fibers, which are animal fibers without impurities, it does not stimulate the internal organs, wounds, etc. even if they come into contact with them. There are few problems. In addition, since it is made of silk fiber, which is a natural material, there is no problem of disposal after use, unlike nonwoven fabric using synthetic fibers.
Claims
1. 絹繊維を切断した短繊維のみから成る医療用絹不織布。 1. Medical silk non-woven fabric consisting only of short fibers obtained by cutting silk fibers.
2. 絹繊維を切断した短繊維をニードルパンチ法で絡合させて成る医療用絹不織 布。 2. Medical non-woven silk fabric obtained by entanglement of short fibers obtained by cutting silk fibers by the needle punch method.
3. 目付が 50〜200 gZmm 2である請求項 2記載の医療用絹不織布。 3. The medical silk nonwoven fabric according to claim 2 , wherein the basis weight is 50 to 200 gZmm2.
4. 絹繊維を切断した短繊維を水流絡合法で絡合させて成る医療用絹不織布。 4. Medical silk non-woven fabric made by entanglement of short fibers obtained by cutting silk fibers by a hydroentanglement method.
5. 目付が 20〜 100 gZmm 2である請求項 4記載の医療用絹不織布。 5. basis weight 20~ 100 gZmm 2 a is 4. The medical silk nonwoven fabric according.
6. 目付が 20〜60 g /mm2である請求項 4記載の医療用絹不織布。 6. basis weight 20 to 60 g / mm 2 a is 4. The medical silk nonwoven fabric according.
7. 絹短繊維の長さが 1〜 1 0 c mである請求項 1〜6のいずれかに記載の医療 用絹不織布。 7. The medical silk nonwoven fabric according to any one of claims 1 to 6, wherein the length of the short silk fibers is 1 to 10 cm.
8. 絹短繊維の長さが 5〜7 cmである請求項 1〜 6のいずれかに記載の医療用 絹不織布。 8. The medical silk nonwoven fabric according to any one of claims 1 to 6, wherein the length of the silk short fibers is 5 to 7 cm.
9. 絹繊維が未精練のものである請求項 1〜6のいずれかに記載の医療用絹不織 布。 9. The medical non-woven silk fabric according to any one of claims 1 to 6, wherein the silk fiber is unrefined.
10. 絹繊維が精練されたものである請求項 1〜 6のいずれかに記載の医療用絹 不織布。 10. The medical silk nonwoven fabric according to any one of claims 1 to 6, wherein the silk fiber is refined.
1 1. 精練した絹繊維を 1〜 10 c mに切断した短繊維をニードルパンチ法で絡 合させて成る手術用ガーゼ。 1 1. Surgical gauze made of short fibers obtained by cutting scoured silk fibers to 1 to 10 cm and entangled by the needle punch method.
12. 目付が 50〜200 gZmm2である請求項 1 1記載の手術用ガーゼ。12. basis weight 50~200 gZmm 2 a surgical gauze of claim 1 1, wherein.
13. 精練した絹繊維を 1〜 10 c mに切断した短繊維を水流絡合法で絡合させ て成る手術用ガーゼ。 13. Surgical gauze formed by entangled short fibers obtained by cutting scoured silk fibers to 1 to 10 cm using the hydroentanglement method.
14. 目付が 20~ 100 gZmm2である請求項 1 3記載の手術用ガーゼ。14. basis weight is 20 ~ 100 gZmm 2 claims 1 to 3, surgical gauze according.
1 5. 目付が 20~ 60 gZmm2である請求項 13記載の手術用ガーゼ。
1 5. basis weight 20 ~ 60 gZmm 2 a surgical gauze of claim 13, wherein.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22713395 | 1995-08-11 | ||
JP7/227133 | 1995-08-11 | ||
JP7/353362 | 1995-12-28 | ||
JP35336295 | 1995-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997007273A1 true WO1997007273A1 (en) | 1997-02-27 |
Family
ID=26527528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1996/002271 WO1997007273A1 (en) | 1995-08-11 | 1996-08-07 | Nonwoven fabric or silk for medical supplies |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1997007273A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002051455A2 (en) * | 2000-12-22 | 2002-07-04 | Kimberly-Clark Worldwide, Inc. | Removal of targeted proteases with proteinaceous wound dressings |
WO2002072937A1 (en) * | 2001-03-14 | 2002-09-19 | Japan As Represented By President Of Tokyo University Of Agriculture And Technology | Non-woven fabric comprising ultra-fine fiber of silk fibroin and/or silk-like material, and method for production thereof |
EP1869238A1 (en) * | 2005-04-13 | 2007-12-26 | The Non Woven Silk Fabric Co., Ltd. | Producing method for non woven silk fabric |
WO2022009835A1 (en) | 2020-07-07 | 2022-01-13 | 三井化学株式会社 | Composite nonwoven fabric and manufacturing method for same |
US20230212798A1 (en) * | 2020-05-28 | 2023-07-06 | Shinwa Corp. | Nonwoven Fabric, and Method for Producing Same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5837431B2 (en) * | 1980-11-22 | 1983-08-16 | 憲雄 道関 | Composite fiber articles using flat wire |
JPH0625956A (en) * | 1992-07-06 | 1994-02-01 | Shizuo Hayashi | Silk nonwoven fabric and its production |
JPH06235154A (en) * | 1993-02-05 | 1994-08-23 | Hiro Internatl:Kk | Silk nonwoven fabric |
JPH07189097A (en) * | 1993-11-17 | 1995-07-25 | Shoichi Kamiya | Article to be attached to skin |
-
1996
- 1996-08-07 WO PCT/JP1996/002271 patent/WO1997007273A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5837431B2 (en) * | 1980-11-22 | 1983-08-16 | 憲雄 道関 | Composite fiber articles using flat wire |
JPH0625956A (en) * | 1992-07-06 | 1994-02-01 | Shizuo Hayashi | Silk nonwoven fabric and its production |
JPH06235154A (en) * | 1993-02-05 | 1994-08-23 | Hiro Internatl:Kk | Silk nonwoven fabric |
JPH07189097A (en) * | 1993-11-17 | 1995-07-25 | Shoichi Kamiya | Article to be attached to skin |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002051455A2 (en) * | 2000-12-22 | 2002-07-04 | Kimberly-Clark Worldwide, Inc. | Removal of targeted proteases with proteinaceous wound dressings |
WO2002051455A3 (en) * | 2000-12-22 | 2002-10-10 | Kimberly Clark Co | Removal of targeted proteases with proteinaceous wound dressings |
WO2002072937A1 (en) * | 2001-03-14 | 2002-09-19 | Japan As Represented By President Of Tokyo University Of Agriculture And Technology | Non-woven fabric comprising ultra-fine fiber of silk fibroin and/or silk-like material, and method for production thereof |
EP1869238A1 (en) * | 2005-04-13 | 2007-12-26 | The Non Woven Silk Fabric Co., Ltd. | Producing method for non woven silk fabric |
EP1869238A4 (en) * | 2005-04-13 | 2008-03-19 | Non Woven Silk Fabric Co Ltd | Producing method for non woven silk fabric |
US20230212798A1 (en) * | 2020-05-28 | 2023-07-06 | Shinwa Corp. | Nonwoven Fabric, and Method for Producing Same |
WO2022009835A1 (en) | 2020-07-07 | 2022-01-13 | 三井化学株式会社 | Composite nonwoven fabric and manufacturing method for same |
KR20230003078A (en) | 2020-07-07 | 2023-01-05 | 미쓰이 가가쿠 가부시키가이샤 | Composite nonwoven fabric and manufacturing method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2081527B1 (en) | Wound care product made from bulked filament tow | |
EP1095179B1 (en) | Nonwoven fabrics and their manufacture and use | |
AU2006264691B2 (en) | Wound dressing material | |
US8461066B2 (en) | Nonwoven from bulked filament tow | |
JP3847778B2 (en) | Trauma bandage | |
JP2710497B2 (en) | Woven alginate fabrics with improved absorbency, use as dressings for wounds and burns, and methods of preparation thereof | |
EP0252743A2 (en) | Stabilized fabric | |
KR102240699B1 (en) | Non-woven cellulosic fibrous fabric with homogeneously merged fibers | |
US20020168911A1 (en) | Absorbent layer for use in hospital supplies | |
Getu et al. | Technical fabric as health care material | |
Chellamani et al. | Medical Textiles: The Spunlace process and its application possibilities for hygiene textiles | |
CN113832607B (en) | Medical non-woven gauze and preparation method and application thereof | |
WO1997007273A1 (en) | Nonwoven fabric or silk for medical supplies | |
JP2003159322A (en) | Silk nonwoven fabric for medical use | |
CN107029276B (en) | Absorbable hemostatic agent deployable laparoscopically | |
CN106930002B (en) | A kind of natural bamboo puree non-woven fabric and preparation method thereof | |
CN105287105A (en) | Coating-free anti-adhesion absorbent pad and production process thereof | |
JP2014050656A (en) | Medical silk pad | |
JP3249286B2 (en) | Nonwoven fabric for medical device sterilization | |
JPH0542812Y2 (en) | ||
RU2191856C1 (en) | Nonwoven material for medicinal short-time usage articles | |
CZ281012B6 (en) | Layered plat fully all synthetic textile sanitary material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CN JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |